Search Results 1-10 of 8076 for ������������������������������������������������r���:za33���

  1. R. Scott Wright, M.D. - Mayo Clinic Faculty Profiles

    At Mayo Clinic, R. Scott Wright, M.D., focuses his research on improved diagnosis, treatment and patient outcomes in acute coronary syndromes and treatment ...

  2. Overview - Infection and Immunity: Raymund R. Razonable - Mayo Clinic Research

    The Infection and Immunity Lab of Raymund R. Razonable, M.D., at Mayo Clinic studies COVID-19 and transplant-related infections such as cytomegalovirus ...

  3. Ian R. Lanza, Ph.D. - Mayo Clinic Faculty Profiles

    The research of Ian R. Lanza, Ph.D., is focused on discovering effective, realistic and economical approaches to prevent and treat metabolic disorders in the ...

  4. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

    (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive.

  5. A Study of R-ICE and Lenalidomide for Treating Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

    The purpose of this study is to assess the side effects and best dose of lenalidomide when given together with rituximab-ifosfamide-carboplatin-etoposide (R ...

  6. Clifford R. Jack, Jr., M.D. - Mayo Clinic Faculty Profiles

    The laboratory of Clifford R. Jack Jr., M.D., is engaged in brain imaging research in cognitive aging, Alzheimer's disease and related disorders. Dr. Jack's ...

  7. Raymund R. Razonable, M.D. - Mayo Clinic Faculty Profiles

    Raymund R. Razonable, M.D., is an infectious disease specialist at Mayo Clinic who studies viral infections, cytomegalovirus and infections related to ...

  8. James R. Cerhan, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    The main research focus of James R. Cerhan, M.D., Ph.D., is using epidemiologic approaches to study the causes and outcomes of cancer in human populations. Dr.

  9. David R. Deyle, M.D. - Mayo Clinic Faculty Profiles

    SUMMARY. Research in the laboratory of David R. Deyle, M.D., is aimed at developing gene and cell therapies for the treatment of genetic disorders through ...

  10. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    This Phase 2, two-arm, open-label study is designed to evaluate the safety, clinical activity, predictive biomarkers and pharmacokinetics/ pharmacodynamics of ...